248 related articles for article (PubMed ID: 7674319)
41. ras oncogene product p21 expression and prognosis of human ovarian tumors.
Yaginuma Y; Yamashita K; Kuzumaki N; Fujita M; Shimizu T
Gynecol Oncol; 1992 Jul; 46(1):45-50. PubMed ID: 1634140
[TBL] [Abstract][Full Text] [Related]
42. p53 mutation in carcinomas arising in ovarian cystic teratomas.
Fujii T; Oguni S; Kikuchi M; Kanai N; Saito K
Pathol Int; 1995 Sep; 45(9):649-54. PubMed ID: 8548037
[TBL] [Abstract][Full Text] [Related]
43. Spontaneous rupture of a hepatic cystadenoma and cystadenocarcinoma: report of two cases.
Lempinen M; Halme L; Numminen K; Arola J; Nordin A; Mäkisalo H
J Hepatobiliary Pancreat Surg; 2005; 12(5):409-14. PubMed ID: 16258811
[TBL] [Abstract][Full Text] [Related]
44. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
[TBL] [Abstract][Full Text] [Related]
45. Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.
Jacobs IJ; Kohler MF; Wiseman RW; Marks JR; Whitaker R; Kerns BA; Humphrey P; Berchuck A; Ponder BA; Bast RC
J Natl Cancer Inst; 1992 Dec; 84(23):1793-8. PubMed ID: 1433368
[TBL] [Abstract][Full Text] [Related]
46. Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance.
Niwa K; Itoh M; Murase T; Morishita S; Itoh N; Mori H; Tamaya T
Br J Cancer; 1994 Dec; 70(6):1191-7. PubMed ID: 7981076
[TBL] [Abstract][Full Text] [Related]
47. [P53-status in primary ovarian carcinomas, ovarian metastases of neoplasms in other sites and benign ovarian tumors: predictive value in comparison to histopathological parameters].
Casper F; Weikel W; Schaffrath M; Kuner RP; Hoffmann G; Pollow B; Pollow K
Zentralbl Gynakol; 2000; 122(3):153-9. PubMed ID: 10756599
[TBL] [Abstract][Full Text] [Related]
48. Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms.
Tibiletti MG; Bernasconi B; Furlan D; Bressan P; Cerutti R; Facco C; Franchi M; Riva C; Cinquetti R; Capella C; Taramelli R
Clin Cancer Res; 2001 Nov; 7(11):3404-9. PubMed ID: 11705855
[TBL] [Abstract][Full Text] [Related]
49. p53 gene mutations and protein accumulation in human ovarian cancer.
Kupryjańczyk J; Thor AD; Beauchamp R; Merritt V; Edgerton SM; Bell DA; Yandell DW
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4961-5. PubMed ID: 8506342
[TBL] [Abstract][Full Text] [Related]
50. Proliferative serous tumors of the ovary. Histologic features and prognosis.
Katzenstein AL; Mazur MT; Morgan TE; Kao MS
Am J Surg Pathol; 1978 Dec; 2(4):339-55. PubMed ID: 736209
[TBL] [Abstract][Full Text] [Related]
51. Loss of heterozygosity at the RB-1 locus and pRB immunostaining in epithelial ovarian tumors: a molecular, immunohistochemical, and clinicopathologic study.
Gras E; Pons C; Machin P; Matias-Guiu X; Prat J
Int J Gynecol Pathol; 2001 Oct; 20(4):335-40. PubMed ID: 11603216
[TBL] [Abstract][Full Text] [Related]
52. MORPHOPHENOTYPIC CHARACTERISTICS OF OVARIAN SEROUS BORDERLINE TUMORS.
Munjishvili V; Barabadze E; Musashvili T; Gachechiladze M; Burkadze G
Georgian Med News; 2019 May; (290):20-25. PubMed ID: 31322508
[TBL] [Abstract][Full Text] [Related]
53. Comparative analysis of histologic homologues of endometrial and ovarian carcinoma.
Caduff RF; Svoboda-Newman SM; Bartos RE; Ferguson AW; Frank TS
Am J Surg Pathol; 1998 Mar; 22(3):319-26. PubMed ID: 9500773
[TBL] [Abstract][Full Text] [Related]
54. Allelotype of papillary serous peritoneal carcinomas.
Cass I; Baldwin RL; Fasylova E; Fields AL; Klinger HP; Runowicz CD; Karlan BY
Gynecol Oncol; 2001 Jul; 82(1):69-76. PubMed ID: 11426964
[TBL] [Abstract][Full Text] [Related]
55. DNA ploidy of ovarian and adnexal cyst fluid. A useful adjunct to cytology.
Greenebaum E; Yee HT; Liu J
Acta Cytol; 1994; 38(2):201-8. PubMed ID: 8147211
[TBL] [Abstract][Full Text] [Related]
56. Periodic acid-Schiff stain as a prognostic indicator in serous and mucinous ovarian tumors.
Aalto ML; Collan Y
Int J Gynaecol Obstet; 1986 Feb; 24(1):27-34. PubMed ID: 2874066
[TBL] [Abstract][Full Text] [Related]
57. [Allelic losses of tumor suppressor gene on chromosome 17 in ovarian cancer].
Sakamoto T; Ogino M; Yamamoto T; Mori H; Okinaga S; Sonoda T; Ueda K; Obi S; Kobayashi T
Nihon Sanka Fujinka Gakkai Zasshi; 1993 May; 45(5):457-63. PubMed ID: 8496636
[TBL] [Abstract][Full Text] [Related]
58. Retinoblastoma protein expression in ovarian epithelial neoplasms.
Niemann TH; Trgovac TL; McGaughy VR; Lewandowski GS; Copeland LJ
Gynecol Oncol; 1998 Jun; 69(3):214-9. PubMed ID: 9648590
[TBL] [Abstract][Full Text] [Related]
59. Cystadenoma and cystadenocarcinoma of the liver: localization of carcinoembryonic antigen.
Tomioka T; Tsuchiya R; Harada N; Tsunoda T; Matsuo T
Jpn J Surg; 1986 Jan; 16(1):62-7. PubMed ID: 3515006
[TBL] [Abstract][Full Text] [Related]
60. Expression of p53 protein and Ki-67 reactivity in ovarian neoplasms. Correlation with histopathology.
Harlozińska A; Bar JK; Sedlaczek P; Gerber J
Am J Clin Pathol; 1996 Mar; 105(3):334-40. PubMed ID: 8602615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
